Division of Pediatric Cardiology, University Children's Hospital, Zurich, Switzerland.
J Interv Cardiol. 2009 Jun;22(3):285-90. doi: 10.1111/j.1540-8183.2009.00460.x. Epub 2009 Apr 2.
Relief of pulmonary artery stenosis before and after cavopulmonary connections (CPC) in patients with single ventricle malformation is essential to optimize pulmonary hemodynamics. We evaluated the risk factors for pulmonary artery stenosis and assessed the outcome after stent implantation.
Seventeen stents in twelve patients were implanted for pulmonary artery stenosis before and after CPC at a mean age of 4.5 (0.1-17.6) years.
Fourteen stents were placed in the left pulmonary artery (82%) and three stents in the right pulmonary artery (18%). One stent was implanted intraoperatively. Mean time between surgery and stent implantation was 28 (1-132) months. The mean (SD) size of the pulmonary artery stenosis was 3.1 +/- 2.1 mm before and 8.1 +/- 3.3 mm (P < 0.001) after stent implantation. Six out of seventeen stents (35.2%) had to be redilated after a mean time interval of 19 (5-48) months. Two patients' stents were removed during the next surgical procedure; both needed an early restenting of the affected vessel. There were no procedure-related complications for stent implantation or redilatation. Anatomical risk factors for pulmonary artery stenosis were right aortic arch and hypoplastic pulmonary arteries, whereas dilatation of the ascending aorta for LPA stenosis and Blalock-Taussig shunt for RPA stenosis were surgical risk factors.
Stent implantation to treat pulmonary artery stenosis in pediatric patients with CPC is effective and can be realized safely. Close follow-up is recommended in patients with risk for pulmonary artery stenosis. During total cavopulmonary connection, previously implanted stents at that site should be left in place or be changed in a hybrid procedure to a larger diameter, because the etiology of stenosis may persist after surgery and the surgical removal could result in vessel injury that promotes restenosis.
在单心室畸形患者行腔静脉肺动脉连接术(CPC)前后,缓解肺动脉狭窄对优化肺血液动力学至关重要。我们评估了肺动脉狭窄的危险因素,并评估了支架植入后的结果。
12 例患者共植入 17 枚支架,用于 CPC 前后的肺动脉狭窄,平均年龄为 4.5(0.1-17.6)岁。
14 枚支架放置于左肺动脉(82%),3 枚支架放置于右肺动脉(18%)。1 枚支架在术中植入。手术与支架植入之间的平均时间为 28(1-132)个月。肺动脉狭窄的平均(SD)直径在支架植入前为 3.1 +/- 2.1mm,植入后为 8.1 +/- 3.3mm(P < 0.001)。17 个支架中有 6 个(35.2%)需要在平均 19(5-48)个月的时间间隔后再次扩张。2 例患者的支架在随后的手术中被取出;两者都需要对受影响的血管进行早期再次支架置入。支架植入或再扩张无手术相关并发症。肺动脉狭窄的解剖学危险因素是右主动脉弓和肺动脉发育不良,而左肺动脉狭窄的升主动脉扩张和右肺动脉狭窄的 Blalock-Taussig 分流术是手术危险因素。
在 CPC 的儿科患者中,支架植入术治疗肺动脉狭窄是有效且安全的。对于有肺动脉狭窄风险的患者,建议进行密切随访。在全腔静脉肺动脉连接术时,应保留或在杂交手术中更换该部位的先前植入支架,使其直径增大,因为狭窄的病因在手术后可能仍然存在,并且支架移除可能会导致血管损伤,从而促进再狭窄。